In patients with anemia of chronic disease (ACD) who experience acute or chronic immune responses [48], the effect of TNF-alpha inhibitors has, however, been found to be independent of iron supplementation [49]. The gene discussed is TNF; the disease is granular corneal dystrophy type II.